Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. (Q40457847)

20 September 2017

Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. (English)

1 reference

20 September 2017

1 reference

Xin Tong

1

1 reference

20 September 2017

Lei Yin

2

1 reference

20 September 2017

Shree Joshi

3

1 reference

20 September 2017

Daniel W Rosenberg

4

1 reference

20 September 2017

Charles Giardina

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

15 February 2005

1 reference

Journal of Biological Chemistry

20 September 2017

1 reference

20 September 2017

280

1 reference

20 September 2017

16

1 reference

20 September 2017

15503-15509

1 reference

The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Prostaglandin synthase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Short chain fatty acids in human large intestine, portal, hepatic and venous blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

SRC proximal and core promoter elements dictate TAF1 dependence and transcriptional repression by histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Structure of the human cyclo-oxygenase-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

The RNA-binding protein HuR regulates the expression of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Butyrate modulates gene and protein expression in human intestinal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Expression profile of histone deacetylase 1 in gastric cancer tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Emerging connections between DNA methylation and histone acetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Identification of genes responsive to sodium butyrate in colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Steroid hormone receptor-mediated histone deacetylation and transcription at the mouse mammary tumor virus promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Requirement of histone deacetylase activity for signaling by STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411978200

21 January 2018

Identifiers

DOI

10.1074/JBC.M411978200

1 reference

20 September 2017

1 reference